Clinical trial
BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal Cancer
NCT00022477 · University of Chicago, Other · Completed
Key facts
| NCT number | NCT00022477 |
|---|---|
| Title | BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal Cancer |
| Official title | A Phase II Study Of Epothilone B Analog BMS-247550 (NSC 710428D) In Patients With Advanced Colorectal Carcinoma |
| Lead sponsor | University of Chicago, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | BMS-247550 |
| Enrollment | 24 |
| Start date | Sep 1, 2001 |
| Primary completion | Oct 1, 2002 |
| Completion | Dec 1, 2004 |
| First posted | Aug 5, 2003 |
| Last update posted | Sep 5, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: